| Not Yet Recruiting | Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer NCT07495098 | University of Vermont | Phase 1 |
| Recruiting | Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer NCT07026110 | RenJi Hospital | N/A |
| Withdrawn | Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer NCT06555263 | Sutro Biopharma, Inc. | Phase 2 |
| Recruiting | TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer NCT06538012 | Essen Biotech | Phase 1 / Phase 2 |
| Completed | SPSIPB vs SAPB for Thoracoscopic Surgery NCT06546839 | Medipol University | N/A |
| Recruiting | A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs NCT06228326 | Krystal Biotech, Inc. | Phase 1 / Phase 2 |
| Recruiting | Primary Tumor Resection for M1a Stage Lung Cancer NCT06547710 | Fudan University | — |
| Unknown | Novel Light Delivery Method for Performing Transbronchial Photodynamic Therapy for Peripheral Lung Cancer NCT06262555 | Taoyuan General Hospital | N/A |
| Terminated | Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced NCT05860296 | SignalChem Lifesciences Corporation | Phase 1 / Phase 2 |
| Unknown | The Alterations of Metabolic Adipo-myokines and Body Composition in End Stage Lung Cancer NCT06060262 | Chang Gung Memorial Hospital | — |
| Completed | Clinical and Molecular Findings in Patients With Cervical/Supraclavicular Metastasis From Non-small-cell Lung NCT05706883 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy NCT05537922 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | — |
| Recruiting | Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer NCT05452005 | University of California, Davis | Phase 1 |
| Recruiting | A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain NCT05419076 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Terminated | Pembro+Chemo in Brain Mets NCT04964960 | John L. Villano, MD, PhD | Phase 2 |
| Completed | DBT for Metastatic Lung Cancer NCT04973436 | Duke University | N/A |
| Active Not Recruiting | A Randomized Pilot Study of Evolocumab Plus Nivolumab/Ipilimumab in Treatment-Naïve Patients With Metastatic N NCT05144529 | Scott Antonia | Phase 2 |
| Recruiting | Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in NCT05078047 | UNICANCER | Phase 3 |
| Withdrawn | Stereotactic Body Radiotherapy for Lung Lesions With Markerless Tracking (MLT) on the VERO® SBRT System NCT06722885 | Universitair Ziekenhuis Brussel | — |
| Recruiting | Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer NCT04405401 | Centre hospitalier de l'Université de Montréal (CHUM) | Phase 2 |
| Active Not Recruiting | NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer NCT04986670 | Tufts University | N/A |
| Unknown | Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Tr NCT04440800 | Royal Marsden NHS Foundation Trust | — |
| Active Not Recruiting | Phase 1 Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Injection of Cisplatin for Stage IV Lun NCT04311762 | University of Vermont | Phase 1 |
| Recruiting | Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer NCT04085315 | Collin Blakely | Phase 1 |
| Terminated | Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivo NCT04069936 | WindMIL Therapeutics | Phase 2 |
| Unknown | Efficacy and Safety of Anlotinib Plus Platinum Plus Pemetrexed in T790M-negative NSCLC NCT03706287 | Sichuan Cancer Hospital and Research Institute | Phase 1 / Phase 2 |
| Completed | A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers NCT03755102 | Memorial Sloan Kettering Cancer Center | EARLY_Phase 1 |
| Unknown | PDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic Abnor NCT03693326 | Asan Medical Center | Phase 2 |
| Unknown | Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer NCT03638765 | Northwest Biotherapeutics | Phase 1 |
| Unknown | Capmatinib in Patients With Non-small Cell Lung Cancer Harboring cMET exon14 Skipping Mutation NCT03693339 | Asan Medical Center | Phase 2 |
| Unknown | Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC NCT03703596 | Sichuan Cancer Hospital and Research Institute | Phase 2 |
| Unknown | Dabrafenib and Trametinib in Patients With Non-small Cell Lung Cancer Harboring V600E BRAF Mutation NCT03543306 | Asan Medical Center | Phase 2 |
| Terminated | ANET Electrosurgery Applicator Pilot Evaluation Study NCT03400748 | Olympus Corporation of the Americas | N/A |
| Completed | Needlescopic-assisted Uniportal vs Uniportal VATS NCT03439696 | IRB of NTUH Hsin-Chu Branch | N/A |
| Unknown | Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy NCT03595813 | Institut Paoli-Calmettes | N/A |
| Terminated | Feasibility Study of the RF Ablation Catheter to Ablate Lung Tumors NCT03272971 | Broncus Medical Inc | N/A |
| Completed | Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (N NCT03184571 | BerGenBio ASA | Phase 2 |
| Completed | Safety of PDT-Photofrin® Prior to Lung Surgery NCT03344861 | Concordia Laboratories Inc. | Phase 1 |
| Completed | Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer NCT03113851 | Peking University Cancer Hospital & Institute | Phase 2 |
| Active Not Recruiting | Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NCT03057106 | Canadian Cancer Trials Group | Phase 2 |
| Completed | A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired R NCT03076164 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Unknown | SBRT Combination With rhGM-CSF and Tα1 for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy NCT02976740 | The First Affiliated Hospital of Xiamen University | Phase 2 |
| Completed | Neck Ultrasound by Respiratory Physicians in Patients With Lung Cancer NCT03970564 | University College Hospital Galway | — |
| Completed | Clinical Validation of the M5L Lung CAD NCT03179150 | Candiolo Cancer Institute - IRCCS | — |
| Terminated | Early Palliative Care in Metastatic Lung Cancer in Northern France NCT02308865 | University Hospital, Lille | N/A |